How to calculate the ASDAS based on C-reactive protein without individual questions from the BASDAI: the BASDAI-based ASDAS formula

被引:14
作者
Concepcion Aranda-Valera, I [1 ]
Garrido-Castro, Juan L. [2 ]
Ladehesa-Pineda, Lourdes [1 ]
Vazquez-Mellado, Janitzia [3 ]
Zarco, Pedro [4 ]
Juanola, Xavier [5 ]
Gonzalez-Navas, Cristina [1 ]
Font-Ugalde, Pilar [1 ]
Carmen Castro-Villegas, M. [1 ]
机构
[1] Reina Sofia Univ Hosp, Dept Rheumatol, Cordoba, Spain
[2] Univ Cordoba, Comp & Numer Anal Dept, Cordoba, Spain
[3] Hosp Gen Mexico City, Rheumatol Dept, Ciudad De Mexico, Mexico
[4] Hosp Univ Fdn Alcorcon, Rheumatol Dept, Madrid, Spain
[5] Univ Barcelona, Hosp Univ Bellvitge, Rheumatol Dept, Barcelona, Spain
关键词
spondyloarthritis; disease activity; DISEASE-ACTIVITY SCORE; ANKYLOSING-SPONDYLITIS; SPONDYLOARTHROPATHIES; REGISTRY;
D O I
10.1093/rheumatology/kez480
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To develop a new equation to calculate the Ankylosing Spondylitis Disease Activity Score based on CRP (ASDAS-CRP) using only the BASDAI total score and CRP. Methods. Axial SpA (axSpA) patients from the Cordoba Spondyloarthritis Registry cohort were recruited as a derivation cohort, while a retrospective sample from the Spanish Rheumatology Society National Registry of Spondyloarthropathies and Ibero American Spondyloarhtritis Registry registers was used as a validation cohort. We built a new equation based only on the BASDAI and CRP, defining a new formula: the BASDAI-based ASDAS (BASDAS). Linear regression analysis was used to determine the coefficients of the equation in the derivation cohort and it was subsequently validated in the validation cohort. Results. A total of 52 axSpA patients in the derivation cohort and 3359 patients in the validation cohort were included. In the derivation cohort, the mean BASDAS [2.24 (s.d. 0.90)] was very similar to the ASDAS-CRP [2.23 (s.d. 0.95)], with a very strong correlation (r = 0.96, P < 0.001). In the validation cohort, the mean BASDAS was 3.31 (s.d. 1.37) and the ASDAS-CRP was 3.19 (s.d. 1.27), which also had a very strong correlation (r = 0.95, P < 0.001). Intraclass correlation coefficients were excellent in both cohorts (0.963 and 0.947, respectively). Conclusion. The BASDAS performs similarly to the ASDAS-CRP and can be calculated with only the BASDAI total score and CRP, allowing evaluation of disease activity in retrospective studies where the individual items of the BASDAI are not available.
引用
收藏
页码:1545 / 1549
页数:5
相关论文
共 17 条
[1]   Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: a prospective longitudinal observational cohort study [J].
Arends, Suzanne ;
Brouwer, Elisabeth ;
van der Veer, Eveline ;
Groen, Henk ;
Leijsma, Martha K. ;
Houtman, Pieternella M. ;
Jansen, Tim L. Th A. ;
Kallenberg, Cees G. M. ;
Spoorenberg, Anneke .
ARTHRITIS RESEARCH & THERAPY, 2011, 13 (03)
[2]   Validation of methods for converting the original Disease Activity Score (DAS) to the DAS28 [J].
Carpenter, Lewis ;
Norton, Sam ;
Nikiphorou, Elena ;
Kiely, Patrick ;
Walsh, David A. ;
Dixey, Josh ;
Young, Adam .
RHEUMATOLOGY INTERNATIONAL, 2018, 38 (12) :2297-2305
[3]   Disease pattern of spondyloarthropathies in Spain:: description of the first national registry (REGISPONSER) -: extended report [J].
Collantes, E. ;
Zarco, P. ;
Munoz, E. ;
Juanola, X. ;
Mulero, J. ;
Fernandez-Sueiro, J. L. ;
Torre-Alonso, J. C. ;
Gratacos, J. ;
Gonzalez, C. ;
Batlle, E. ;
Fernandez, P. ;
Linares, L. F. ;
Brito, E. ;
Carmona, L. .
RHEUMATOLOGY, 2007, 46 (08) :1309-1315
[4]   Validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with early spondyloarthritis from the Esperanza programme [J].
Fernandez-Espartero, C. ;
de Miguel, E. ;
Loza, E. ;
Tomero, E. ;
Gobbo, M. ;
Descalzo, M. A. ;
Collantes-Estevez, E. ;
Mulero, J. ;
Munoz-Fernandez, S. ;
Zarco, P. ;
Carmona, L. .
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (07) :1350-1355
[5]  
GARRETT S, 1994, J RHEUMATOL, V21, P2286
[6]  
Jones SD, 1996, BRIT J RHEUMATOL, V35, P66
[7]   Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis [J].
Lukas, C. ;
Landewe, R. ;
Sieper, J. ;
Dougados, M. ;
Davis, J. ;
Braun, J. ;
van der Linden, S. ;
van der Heijde, D. .
ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (01) :18-24
[8]   Calculating the Ankylosing Spondylitis Disease Activity Score If the Conventional C-Reactive Protein Level Is Below the Limit of Detection or If High-Sensitivity C-Reactive Protein Is Used: An Analysis in the DESIR Cohort [J].
Machado, Pedro ;
Navarro-Compan, Victoria ;
Landewe, Robert ;
van Gaalen, Floris A. ;
Roux, Christian ;
van der Heijde, Desiree .
ARTHRITIS & RHEUMATOLOGY, 2015, 67 (02) :408-413
[9]   Is it time to replace BASDAI with ASDAS? [J].
Machado, Pedro ;
Landewe, Robert .
NATURE REVIEWS RHEUMATOLOGY, 2013, 9 (07) :388-390
[10]   How to measure disease activity in axial spondyloarthritis? [J].
Machado, Pedro ;
van der Heijde, Desiree .
CURRENT OPINION IN RHEUMATOLOGY, 2011, 23 (04) :339-345